| Late results of a prospective study of direct intra-arterial urokinase infusion for peripheral arterial and bypass graft occlusions. | |
| | |
MedLine Citation:
|
PMID: 7655844 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The outcome of 72 direct intra-arterial urokinase infusions was studied prospectively. Thirty four were performed for native arterial occlusion and 38 for bypass graft occlusion; the immediate success rates were 67.5 and 84% respectively. The overall incidence of complications was 26%. Median follow-up was 36 (range 1-60) months. Seventeen patients (27%) died during follow-up; nine (14%) required a major amputation. Among patients with native arterial occlusion, 29% had no adjunctive procedure after thrombolysis; of these patients, 85% remained patent at a median of 21 (range 3-42) months. Among bypass occluded patients, only two (6%) had no lesion revealed after successful lysis; both bypasses remain patent at 54 and 58 months respectively. For patients treated with balloon angioplasty immediately after successful thrombolysis, 62% with native arterial occlusion remained patent at a median of 39 (range 2-60) months, whereas only 27% of bypass occlusion patients were patent at a median of 11 (range 2-40) months. Of patients requiring a surgical procedure after thrombolysis, 23 new bypasses (15 vein, eight prosthetic) were placed (nine in native arterial occlusion patients, 14 in bypass occlusion patients). In addition, there were 15 other surgical procedures, including six thrombectomies, four vein patch angioplasties, four vein jump grafts and one endarterectomy. The primary and secondary patencies for the 15 new vein bypasses placed were 81 and 88% respectively at a median follow-up of 36 months. Good immediate results were experienced with urokinase thrombolysis for peripheral arterial and graft occlusions. However, multiple adjunctive procedures were required to maintain patency.(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
R T Chalmers; J J Hoballah; T F Kresowik; A Y Synn; N Nakagawa; W J Sharp; J D Corson |
Related Documents
:
|
22150954 - Left main disease associated with an anomalous left anterior descending artery. 21703034 - Carotid axillary bypass in a patient with blocked subclavian stents: a case report. 18270194 - Impact of perioperative transesophageal echocardiography in aortic valve replacement. 2784074 - Coronary artery bypass grafts: new universal markers. 22563184 - Melena-associated regional portal hypertension caused by splenic arteriovenous fistula. 10591564 - Ingested ring-pull causing bronchoesophageal fistula and transection of the left main b... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cardiovascular surgery (London, England) Volume: 3 ISSN: 0967-2109 ISO Abbreviation: Cardiovasc Surg Publication Date: 1995 Jun |
Date Detail:
|
Created Date: 1995-10-05 Completed Date: 1995-10-05 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9308765 Medline TA: Cardiovasc Surg Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 293-7 Citation Subset: IM |
Affiliation:
|
Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City 52242-1086, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Amputation Combined Modality Therapy Endarterectomy Female Follow-Up Studies Graft Occlusion, Vascular / drug therapy*, mortality Humans Infusions, Intra-Arterial Ischemia / drug therapy*, mortality Leg / blood supply* Male Middle Aged Prospective Studies Prosthesis Failure Reoperation Survival Rate Thrombectomy Thrombolytic Therapy / methods* Thrombosis / drug therapy*, mortality Urokinase-Type Plasminogen Activator / administration & dosage*, adverse effects |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.21.73/Urokinase-Type Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Endothelial cell injury in the human saphenous vein: a comparative study of two valvulotomes.
Next Document: Effects of completion angiography on the outcome of carotid endarterectomy.